Food And Drug Administration-Treatment Of Breast Cancer-Healthday News-Avastin

Avastin Boosted Survival for Type of Aggressive Breast Cancer: Study

WEDNESDAY, Dec. 7 (Healthday News) -- In November, the U.S. Food And Drug Administration revoked its approval of the drug Avastin for the treatment of Breast Cancer. But, a new study suggests that the drug can boost the survival of women with a specific type of aggressive breast tumor when used in conjunction with two other medications. read more..

source:http://yhoo.it/up1ntJ